source
- Ambros Therapeutics merges with Werewolf, raises $150M to fund phase 3 trial of rare disease drugAmbros Therapeutics announced an all‑stock reverse merger with Werewolf Therapeutics, accompanied by a $150 million private placement. The transaction will see the combined company operate under th…
- Early Alert: Epidural Kit Issue from Medical Action IndustriesMedical Action Industries is correcting epidural kits containing recalled Huons Co. sodium chloride ampules.fda medwatch · 19h ago↗ source